Johns Hopkins University researchers plan to use psychedelic drugs to attack some of society's toughest problems at a new research center, including smoking, depression, alcoholism, Alzheimer's disease, anorexia, Lyme disease and even addiction to opioids.
The new Center for Psychedelic & Consciousness Research opened this month in Baltimore.
Read more
What do we mean by ego death? Three different perspectives break it down here, here and here.
Read more
New research shows that the near-death experience may reflect changes in the same chemical system in the brain that is targeted by drugs like ketamine.
Read more
The largest psychedelic research center in the world, and the first of its kind in the United States, will open at Johns Hopkins Medicine in Maryland. Funded by $17 million from private donors, the Center for Psychedelic and Consciousness Research will conduct research into the use of psychedelic drugs in the treatment of addiction, PTSD, depression, Alzheimer's disease and more.
Read more
Here’s a look at the latest research of DMT and the brain.
Read more